Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Creative Medical Technology Holdings (CELZ) Interest & Investment Income (2022 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Interest & Investment Income for 4 consecutive years, with $37100.0 as the latest value for Q3 2025.

  • On a quarterly basis, Interest & Investment Income fell 46.65% to $37100.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $121358.0, a 61.1% decrease, with the full-year FY2024 number at $250380.0, down 24.94% from a year prior.
  • Interest & Investment Income was $37100.0 for Q3 2025 at Creative Medical Technology Holdings, up from $30217.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $93215.0 in Q4 2023 to a low of $22381.0 in Q1 2025.
  • A 4-year average of $59535.7 and a median of $62245.0 in 2022 define the central range for Interest & Investment Income.
  • Peak YoY movement for Interest & Investment Income: surged 134.31% in 2023, then plummeted 72.57% in 2025.
  • Creative Medical Technology Holdings' Interest & Investment Income stood at $62245.0 in 2022, then skyrocketed by 49.76% to $93215.0 in 2023, then tumbled by 66.04% to $31660.0 in 2024, then grew by 17.18% to $37100.0 in 2025.
  • Per Business Quant, the three most recent readings for CELZ's Interest & Investment Income are $37100.0 (Q3 2025), $30217.0 (Q2 2025), and $22381.0 (Q1 2025).